日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CTIM-22. WINDOW OF OPPORTUNITY STUDY OF NIVOLUMAB AND IPILIMUMAB IN PEOPLE WITH NEUROFIBROMATOSIS TYPE 1 AND NEWLY DIAGNOSED MALIGNANT AND PRE-MALIGNANT PERIPHERAL NERVE SHEATH TUMORS

CTIM-22. 神经纤维瘤病 1 型患者合并新诊断的恶性及癌前周围神经鞘瘤患者接受纳武利尤单抗和伊匹木单抗治疗的机会窗口研究

Zwimpfer, Tibor A; Fereday, Sian; Pandey, Ahwan; Ariyaratne, Dinuka; Jayawardana, Madawa W; Twomey, Laura; Laumont, Céline M; Kennedy, Catherine J; Bolithon, Adelyn; Meagher, Nicola S; Milne, Katy; Hamilton, Phineas; Alsop, Jennifer; Antoniou, Antonis C; Au-Yeung, George; Beckmann, Matthias W; Berrington de Gonzalez, Amy; Bisinotto, Christiani; Blome, Freya; Bodelon, Clara; Boros, Jessica; Brand, Alison H; Carney, Michael E; Cazorla-Jiménez, Alicia; Chiu, Derek S; Christie, Elizabeth L; Chudecka-Głaz, Anita; Coulson, Penny; Cushing-Haugen, Kara L; Cybulski, Cezary; Darcy, Kathleen M; David, Cath; Davidson, Trent; Ekici, Arif B; Elishaev, Esther; Emons, Julius; Engler, Tobias; Farrell, Rhonda; Fischer, Anna; García-Closas, Montserrat; Gentry-Maharaj, Aleksandra; Ghatage, Prafull; Glasspool, Rosalind; Harter, Philipp; Hartkopf, Andreas D; Hartmann, Arndt; Heikaus, Sebastian; Hernandez, Brenda Y; Hettiaratchi, Anusha; Heublein, Sabine; Huntsman, David G; Jimenez-Linan, Mercedes; Jones, Michael E; Kang, Eunyoung; Kaznowska, Ewa; Kluz, Tomasz; Kommoss, Felix K F; Konecny, Gottfried; Kruitwagen, Roy F P M; Kwon, Jessica; Lambrechts, Diether; Lee, Cheng-Han; Lester, Jenny; Leung, Samuel C Y; Leung, Yee; Linder, Anna; Lissowska, Jolanta; Loverix, Liselore; Lubiński, Jan; Mateoiu, Constantina; McNeish, Iain A; Moubarak, Malak; Nelson, Gregg S; Nevins, Nikilyn; Olawaiye, Alexander B; Olbrecht, Siel; Orsulic, Sandra; Osorio, Ana; Quinn, Carmel M; Mohan, Ganendra Raj; Ray-Coquard, Isabelle; Rodríguez-Antona, Cristina; Roxburgh, Patricia; Ruebner, Matthias; Salfinger, Stuart G; Samra, Spinder; Schoemaker, Minouk J; Sinn, Hans-Peter; Sonke, Gabe S; Steele, Linda; Stewart, Colin J R; Talhouk, Aline; Tan, Adeline; Tarney, Christopher M; Taylor, Sarah E; Van de Vijver, Koen K; van der Aa, Maaike A; Van Gorp, Toon; Van Nieuwenhuysen, Els; van-Wagensveld, Lilian; Wahner-Hendrickson, Andrea E; Walter, Christina; Wang, Chen; Welz, Julia; Wentzensen, Nicolas; Wilkens, Lynne R; Winham, Stacey J; Winterhoff, Boris; Anglesio, Michael S; Berchuck, Andrew; Candido Dos Reis, Francisco J; Cohen, Paul A; Conrads, Thomas P; Crowe, Philip; Doherty, Jennifer A; Fasching, Peter A; Fortner, Renée T; García, María J; Gayther, Simon A; Goodman, Marc T; Gronwald, Jacek; Harris, Holly R; Heitz, Florian; Horlings, Hugo M; Karlan, Beth Y; Kelemen, Linda E; Maxwell, G Larry; Menon, Usha; Modugno, Francesmary; Neuhausen, Susan L; Schildkraut, Joellen M; Staebler, Annette; Sundfeldt, Karin; Swerdlow, Anthony J; Vergote, Ignace; Wu, Anna H; Brenton, James D; Pharoah, Paul D P; Pearce, Celeste Leigh; Pike, Malcolm C; Goode, Ellen L; Ramus, Susan J; Köbel, Martin; Nelson, Brad H; DeFazio, Anna; Friedlander, Michael L; Bowtell, David D L; Garsed, Dale W; Blakeley, Jaishri; Ye, Xiaobu; Steibel, Jolene; Chi, Ping; Sait, Sameer Farouk; Piotrowski, Anna; Kim, AeRang; Makri, Stavriani; Pratilas, Christine; Wollett, Jessica; Michalik, Amber; Belzberg, Allan; Caterina, Michael; Ahlawat, Shivani; Lim, Michael; Hirbe, Angela

Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer.

利用铁稳态失调来根除顽固性高级别浆液性卵巢癌

Cerra Carmelo, Tancock Madeleine R C, Thio Niko, Koo Ada, Wong AnnRann, J Cowley Karla, Varshney Swati, Willis Madelynne O, Simpson Kaylene J, Bowtell David D L, Sanij Elaine, Christie Elizabeth L, Pearson Richard B, Kang Jian, Chan Keefe T

Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancers

靶向ALC1可以安全地扩大PARP抑制剂在高级别浆液性卵巢癌中的治疗应用范围。

Aubuchon, Lindsey N; Wong, Deanna H; Ramakrishnan, Natasha M; Reddy, Rohan; Compadre, Amanda; Lomonosova, Elena; Jackson, Kathleen E; Kemper, Danielle; Mehta, Vrutti; Zoberi, Kellen; Khabele, Dineo; Christie, Elizabeth L; Mullen, Mary M; Verma, Priyanka

Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer

在高级别浆液性卵巢癌中,PARP抑制剂治疗后肿瘤样本中,小规模突变作为耐药机制并不常见。

Burdett, Nikki L; Willis, Madelynne O; Pandey, Ahwan; Fereday, Sian; DeFazio, Anna; Bowtell, David D L; Christie, Elizabeth L

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

三阴性乳腺癌中雌激素受体β的表达与复发或生存无关

Takano, Elena A; Younes, Melissa M; Meehan, Katie; Spalding, Lisa; Yan, Max; Allan, Prue; Fox, Stephen B; Redfern, Andy; Clouston, David; Giles, Graham G; Christie, Elizabeth L; Anderson, Robin L; Zethoven, Magnus; Phillips, Kelly-Anne; Gorringe, Kylie; Britt, Kara L

Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

RB1 缺失和 BRCA 缺陷同时存在预示着输卵管卵巢高级别浆液性癌患者免疫反应增强和长期生存率提高。

Saner, Flurina A M; Takahashi, Kazuaki; Budden, Timothy; Pandey, Ahwan; Ariyaratne, Dinuka; Zwimpfer, Tibor A; Meagher, Nicola S; Fereday, Sian; Twomey, Laura; Pishas, Kathleen I; Hoang, Therese; Bolithon, Adelyn; Traficante, Nadia; Alsop, Kathryn; Christie, Elizabeth L; Kang, Eun-Young; Nelson, Gregg S; Ghatage, Prafull; Lee, Cheng-Han; Riggan, Marjorie J; Alsop, Jennifer; Beckmann, Matthias W; Boros, Jessica; Brand, Alison H; Brooks-Wilson, Angela; Carney, Michael E; Coulson, Penny; Courtney-Brooks, Madeleine; Cushing-Haugen, Kara L; Cybulski, Cezary; El-Bahrawy, Mona A; Elishaev, Esther; Erber, Ramona; Gayther, Simon A; Gentry-Maharaj, Aleksandra; Blake Gilks, C; Harnett, Paul R; Harris, Holly R; Hartmann, Arndt; Hein, Alexander; Hendley, Joy; Hernandez, Brenda Y; Jakubowska, Anna; Jimenez-Linan, Mercedes; Jones, Michael E; Kaufmann, Scott H; Kennedy, Catherine J; Kluz, Tomasz; Koziak, Jennifer M; Kristjansdottir, Björg; Le, Nhu D; Lener, Marcin; Lester, Jenny; Lubiński, Jan; Mateoiu, Constantina; Orsulic, Sandra; Ruebner, Matthias; Schoemaker, Minouk J; Shah, Mitul; Sharma, Raghwa; Sherman, Mark E; Shvetsov, Yurii B; Singh, Naveena; Rinda Soong, T; Steed, Helen; Sukumvanich, Paniti; Talhouk, Aline; Taylor, Sarah E; Vierkant, Robert A; Wang, Chen; Widschwendter, Martin; Wilkens, Lynne R; Winham, Stacey J; Anglesio, Michael S; Berchuck, Andrew; Brenton, James D; Campbell, Ian; Cook, Linda S; Doherty, Jennifer A; Fasching, Peter A; Fortner, Renée T; Goodman, Marc T; Gronwald, Jacek; Huntsman, David G; Karlan, Beth Y; Kelemen, Linda E; Menon, Usha; Modugno, Francesmary; Pharoah, Paul D P; Schildkraut, Joellen M; Sundfeldt, Karin; Swerdlow, Anthony J; Goode, Ellen L; DeFazio, Anna; Köbel, Martin; Ramus, Susan J; Bowtell, David D L; Garsed, Dale W

The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

高级别浆液性卵巢癌长期生存者的基因组和免疫图谱

Garsed, Dale W; Pandey, Ahwan; Fereday, Sian; Kennedy, Catherine J; Takahashi, Kazuaki; Alsop, Kathryn; Hamilton, Phineas T; Hendley, Joy; Chiew, Yoke-Eng; Traficante, Nadia; Provan, Pamela; Ariyaratne, Dinuka; Au-Yeung, George; Bateman, Nicholas W; Bowes, Leanne; Brand, Alison; Christie, Elizabeth L; Cunningham, Julie M; Friedlander, Michael; Grout, Bronwyn; Harnett, Paul; Hung, Jillian; McCauley, Bryan; McNally, Orla; Piskorz, Anna M; Saner, Flurina A M; Vierkant, Robert A; Wang, Chen; Winham, Stacey J; Pharoah, Paul D P; Brenton, James D; Conrads, Thomas P; Maxwell, George L; Ramus, Susan J; Pearce, Celeste Leigh; Pike, Malcolm C; Nelson, Brad H; Goode, Ellen L; DeFazio, Anna; Bowtell, David D L

Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer

靶向PI3K/AKT/mTOR通路治疗上皮性卵巢癌,为铂类耐药卵巢癌提供治疗选择

Rinne, Natasha; Christie, Elizabeth L; Ardasheva, Anastasia; Kwok, Chun Hei; Demchenko, Nikita; Low, Caroline; Tralau-Stewart, Catherine; Fotopoulou, Christina; Cunnea, Paula

Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.

临床 MDR1 抑制剂可增强 Smac 模拟物的生物利用度,从而杀死小鼠 LSC 并提高 AML 模型中的生存率

Morrish Emma, Copeland Anthony, Moujalled Donia M, Powell Jason A, Silke Natasha, Lin Ann, Jarman Kate E, Sandow Jarrod J, Ebert Gregor, Mackiewicz Liana, Beach Jessica A, Christie Elizabeth L, Lewis Alexander C, Pomilio Giovanna, Fischer Karla C, MacPherson Laura, Bowtell David D L, Webb Andrew I, Pellegrini Marc, Dawson Mark A, Pitson Stuart M, Wei Andrew H, Silke John, Brumatti Gabriela

Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer

基因组筛选发现抗凋亡基因是卵巢癌化疗耐药性的可靶向介质

Stover, Elizabeth H; Baco, Maria B; Cohen, Ofir; Li, Yvonne Y; Christie, Elizabeth L; Bagul, Mukta; Goodale, Amy; Lee, Yenarae; Pantel, Sasha; Rees, Matthew G; Wei, Guo; Presser, Adam G; Gelbard, Maya K; Zhang, Weiqun; Zervantonakis, Ioannis K; Bhola, Patrick D; Ryan, Jeremy; Guerriero, Jennifer L; Montero, Joan; Liang, Felice J; Cherniack, Andrew D; Piccioni, Federica; Matulonis, Ursula A; Bowtell, David D L; Sarosiek, Kristopher A; Letai, Anthony; Garraway, Levi A; Johannessen, Cory M; Meyerson, Matthew